| [1] |
Walker M D, Shane E. Postmenopausal osteoporosis. reply[J]. N Engl J Med, 2024, 390(7): 676. DOI: 10.1056/nejmc2314624.
|
| [2] |
中国疾病预防控制中心慢性非传染性疾病预防控制中心, 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查报告-2018[M]. 北京: 人民卫生出版社, 2021.
|
| [3] |
|
| [4] |
Sipilä S, Törmäkangas T, Sillanpää E, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity[J]. J Cachexia Sarcopenia Muscle, 2020, 11(3): 698-709. DOI: 10.1002/jcsm.12547.
|
| [5] |
Yoon H, Sung E, Kang J H, et al. Association between body fat and bone mineral density in Korean adults: a cohort study[J]. Sci Rep, 2023, 13(1): 17462. DOI: 10.1038/s41598-023-44537-1.
|
| [6] |
D'onofrio G, Kirschner J, Prather H, et al. Musculoskeletal exercise: Its role in promoting health and longevity[J]. Prog Cardiovasc Dis, 2023, 77: 25-36. DOI: 10.1016/j.pcad.2023.02.006.
|
| [7] |
Almeida M, Laurent M R, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology[J]. Physiol Rev, 2017, 97(1): 135-187. DOI: 10.1152/physrev.00033.2015.
|
| [8] |
广东省中医药学会. 《原发性骨质疏松症(骨痿)中医临床诊疗指南》[Z]. 2021.
|
| [9] |
|
| [10] |
Cartee G D, Hepple R T, Bamman M M, et al. Exercise promotes healthy aging of skeletal muscle[J]. Cell Metab, 2016, 23(6): 1034-1047. DOI: 10.1016/j.cmet.2016.05.007.
|
| [11] |
Heng M W Y, Chan A W D, Man R E K, et al. Individual and combined associations of sarcopenia, osteoporosis and obesity with frailty in a multi-ethnic Asian older adult population[J]. BMC Geriatr, 2023, 23(1): 802. DOI: 10.1186/s12877-023-04500-1.
|
| [12] |
王庆谚, 李佳, 郑洪新. 从"肾虚络病,瘀阻骨络"探讨原发性骨质疏松症中医病机[J]. 中华中医药杂志, 2022, 37(2): 756-759.
|
| [13] |
|
| [14] |
Nguyen T P H, Yong H E J, Chollangi T, et al. Altered downstream target gene expression of the placental Vitamin D receptor in human idiopathic fetal growth restriction[J]. Cell Cycle, 2018, 17(2): 182-190. DOI: 10.1080/15384101.2017.1405193.
|
| [15] |
Du Y W, Xie B H, Wang M Y, et al. Roles of sex hormones in mediating the causal effect of vitamin D on osteoporosis: a two-step Mendelian randomization study[J]. Front Endocrinol, 2023, 14: 1159241. DOI: 10.3389/fendo.2023.1159241.
|
| [16] |
Ji J, Lu R N, Zhou X J, et al. 1, 25-Dihydroxyvitamin D 3 contributes to regulating mammary calcium transport and modulates neonatal skeletal growth and turnover cooperatively with calcium[J]. Am J Physiol Endocrinol Metab, 2011, 301(5): E889-E900. DOI: 10.1152/ajpendo.00173.2011.
|
| [17] |
Chen J, Zhang J, Li J, et al. 1, 25-dihydroxyvitamin D deficiency accelerates aging-related osteoarthritis via downregulation of Sirt1 in mice[J]. Int J Biol Sci, 2023, 19(2): 610-624. DOI: 10.7150/ijbs.78785.
|
| [18] |
Agoro R, White K E. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions[J]. Nat Rev Nephrol, 2023, 19(3): 185-193. DOI: 10.1038/s41581-022-00665-x.
|
| [19] |
Simic P, Babitt J L. Regulation of FGF23: beyond bone[J]. Curr Osteoporos Rep, 2021, 19(6): 563-573. DOI: 10.1007/s11914-021-00703-w.
|
| [20] |
钱朝良, 邢涛, 李向洲, 等. FGF23对慢性肾脏病的矿物质和骨代谢异常的作用及中药干预的研究[J]. 中国骨质疏松杂志, 2024, 30(2): 263-269, 289.
|
| [21] |
Murali S K, Roschger P, Zeitz U, et al. FGF23 regulates bone mineralization in a 1, 25(OH) 2 D 3 and klotho-independent manner[J]. J Bone Miner Res, 2016, 31(1): 129-142. DOI: 10.1002/jbmr.2606.
|
| [22] |
龚华乾, 田兴中, 陈雨佳, 等. 黄芪多糖对地塞米松诱导的MC-3T3-E1成骨细胞FGF23、Klotho mRNA及蛋白表达的影响[J]. 时珍国医国药, 2023, 34(6): 1349-1353.
|
| [23] |
Michigami T, Ozono K. Roles of phosphate in skeleton[J]. Front Endocrinol, 2019, 10: 180. DOI: 10.3389/fendo.2019.00180.
|
| [24] |
Lin Z N, Yu G S, Xiong S R, et al. Leptin and melatonin's effects on OVX rodents' bone metabolism[J]. Front Endocrinol, 2023, 14: 1185476. DOI: 10.3389/fendo.2023.1185476.
|
| [25] |
Ishii T, Ruiz-Torruella M, Kim J Y, et al. Soluble Sema4D cleaved from osteoclast precursors by TACE suppresses osteoblastogenesis[J]. J Cell Mol Med, 2023, 27(12): 1750-1756. DOI: 10.1111/jcmm.17416.
|
| [26] |
|